Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease - PubMed (original) (raw)
Comparative Study
. 2007 Aug 1;55(10):1074-84.
doi: 10.1002/glia.20526.
Affiliations
- PMID: 17551926
- DOI: 10.1002/glia.20526
Comparative Study
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
Danielle A Simmons et al. Glia. 2007.
Abstract
Huntington's Disease (HD) is characterized primarily by neuropathological changes in the striatum, including loss of medium-spiny neurons, nuclear inclusions of the huntingtin protein, gliosis, and abnormally high iron levels. Information about how these conditions interact, or about the temporal order in which they appear, is lacking. This study investigated if, and when, iron-related changes occur in the R6/2 transgenic mouse model of HD and compared the results with those from HD patients. Relative to wild-type mice, R6/2 mice had increased immunostaining for ferritin, an iron storage protein, in the striatum beginning at 2-4 weeks postnatal and in cortex and hippocampus starting at 5-7 weeks. The ferritin staining was found primarily in microglia, and became more pronounced as the mice matured. Ferritin-labeled microglia in R6/2 mice appeared dystrophic in that they had thick, twisted processes with cytoplasmic breaks; some of these cells also contained the mutant huntingtin protein. Brains from HD patients (Vonsattel grades 0-4) also had increased numbers of ferritin-containing microglia, some of which were dystrophic. The cells were positive for Perl's stain, indicating that they contained abnormally high levels of iron. These results provide the first evidence that perturbations to iron metabolism in HD are predominately associated with microglia and occur early enough to be important contributors to HD progression.
Copyright 2007 Wiley-Liss, Inc.
Similar articles
- Microglia density decreases with age in a mouse model of Huntington's disease.
Ma L, Morton AJ, Nicholson LF. Ma L, et al. Glia. 2003 Sep;43(3):274-80. doi: 10.1002/glia.10261. Glia. 2003. PMID: 12898706 - Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity.
Lopes KO, Sparks DL, Streit WJ. Lopes KO, et al. Glia. 2008 Aug 1;56(10):1048-60. doi: 10.1002/glia.20678. Glia. 2008. PMID: 18442088 - MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
Bartzokis G, Tishler TA. Bartzokis G, et al. Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33. Cell Mol Biol (Noisy-le-grand). 2000. PMID: 10875443 - The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
Gil JM, Rego AC. Gil JM, et al. Brain Res Rev. 2009 Mar;59(2):410-31. doi: 10.1016/j.brainresrev.2008.12.001. Epub 2008 Dec 16. Brain Res Rev. 2009. PMID: 19118572 Review. - Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.
Stack EC, Matson WR, Ferrante RJ. Stack EC, et al. Ann N Y Acad Sci. 2008 Dec;1147:79-92. doi: 10.1196/annals.1427.008. Ann N Y Acad Sci. 2008. PMID: 19076433 Review.
Cited by
- Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.
Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Ru Q, et al. Signal Transduct Target Ther. 2024 Oct 14;9(1):271. doi: 10.1038/s41392-024-01969-z. Signal Transduct Target Ther. 2024. PMID: 39396974 Review. - Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities.
Samuel Olajide T, Oyerinde TO, Omotosho OI, Okeowo OM, Olajide OJ, Ijomone OM. Samuel Olajide T, et al. Neuroprotection. 2024 Sep;2(3):182-195. doi: 10.1002/nep3.56. Epub 2024 Sep 15. Neuroprotection. 2024. PMID: 39364217 Free PMC article. - Knockdown of microglial iron import gene, Slc11a2, worsens cognitive function and alters microglial transcriptional landscape in a sex-specific manner in the APP/PS1 model of Alzheimer's disease.
Robertson KV, Rodriguez AS, Cartailler JP, Shrestha S, Schleh MW, Schroeder KR, Valenti AM, Kramer AT, Harrison FE, Hasty AH. Robertson KV, et al. J Neuroinflammation. 2024 Sep 27;21(1):238. doi: 10.1186/s12974-024-03238-w. J Neuroinflammation. 2024. PMID: 39334471 Free PMC article. - Microglia in Neurodegenerative Diseases.
Awogbindin I, Wanklin M, Verkhratsky A, Tremblay MÈ. Awogbindin I, et al. Adv Neurobiol. 2024;37:497-512. doi: 10.1007/978-3-031-55529-9_27. Adv Neurobiol. 2024. PMID: 39207709 Review. - Correlation of metal ions with specific brain region volumes in neurodegenerative diseases.
Melek İM, Kuş B, Kaptan Z, Petekkaya E. Melek İM, et al. Turk J Med Sci. 2023 Aug 26;53(5):1465-1475. doi: 10.55730/1300-0144.5714. eCollection 2023. Turk J Med Sci. 2023. PMID: 38812995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases